{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:46:46Z","timestamp":1791334006961,"version":"4.3.1"},"reference-count":189,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.00123","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:01:02Z","timestamp":1517875262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":147,"title":["Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture"],"prefix":"10.3389","volume":"9","author":[{"given":"Daniela S.","family":"Raj\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1128\/JVI.02077-13","article-title":"CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection","volume":"88","author":"Alam","year":"2014","journal-title":"J. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4161\/hv.8.1.17623","article-title":"The rationale for quadrivalent influenza vaccines","volume":"8","author":"Ambrose","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1750-2659.2010.00183.x","article-title":"The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults","volume":"5","author":"Ambrose","year":"2011","journal-title":"Influenza Other Respir. Viruses"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e00275","DOI":"10.1128\/mSphere.00275-16","article-title":"A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses","volume":"1","author":"Anderson","year":"2016","journal-title":"mSphere"},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/irv.12193","article-title":"Population dynamics of cocirculating swine influenza A viruses in the United States from 2009 to 2012","volume":"7","author":"Anderson","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"B6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/mt.2013.162","article-title":"Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1016\/j.vaccine.2014.08.031","article-title":"Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population","volume":"32","author":"Atsmon","year":"2014","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1016\/j.vaccine.2011.01.039","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of FluBlok(R) trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age","volume":"29","author":"Baxter","year":"2011","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults","volume":"197","author":"Bernstein","year":"2008","journal-title":"J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1016\/j.vaccine.2011.05.040","article-title":"Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis","volume":"29","author":"Beyer","year":"2011","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1016\/j.vaccine.2016.05.030","article-title":"A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs","volume":"34","author":"Borggren","year":"2016","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.vaccine.2012.11.047","article-title":"Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus","volume":"31","author":"Boyd","year":"2013","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1128\/CVI.00315-12","article-title":"Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs","volume":"19","author":"Braucher","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"ofx111","DOI":"10.1093\/ofid\/ofx111","article-title":"Live-attenuated influenza vaccine effectiveness in children from 2009 to 2015-2016: a systematic review and meta-analysis","volume":"4","author":"Caspard","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"B19","volume-title":"Labeling of Equine Influenza and Swine Influenza Vaccines. Notice No 07-17","year":"2007"},{"key":"B20","unstructured":"FLUAD\u2122 Flu Vaccine With Adjuvant.2016"},{"key":"B21","unstructured":"ACIP Votes Down Use of LAIV for 2016-2017 flu Season"},{"key":"B22","unstructured":"August 24, 2017 Seasonal Influenza Vaccine Effectiveness, 2005-2017"},{"key":"B23","unstructured":"Case Count: Detected, U.S. Human Infections with H3N2v by State Since August 2011"},{"key":"B24","unstructured":"Estimated Influenza Illnesses, Medical Visits, Hospitalizations, and Deaths Averted by Vaccination in the United States"},{"key":"B25","unstructured":"Avian Influenza A Virus Infections in Humans"},{"key":"B26","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0123969","DOI":"10.1371\/journal.pone.0123969","article-title":"Phase 1 study of pandemic H1 DNA vaccine in healthy adults","volume":"10","author":"Crank","year":"2015","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/S0264-410X(98)00494-0","article-title":"Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes","volume":"17","author":"Crawford","year":"1999","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e00720","DOI":"10.1128\/JVI.00720-16","article-title":"Replicating single-cycle adenovirus vectors generate amplified influenza vaccine responses","volume":"91","author":"Crosby","year":"2017","journal-title":"J. Virol."},{"key":"B30","first-page":"195","article-title":"New developments in vaccine research\u2013unveiling the secret of vaccine adjuvants","volume":"12","author":"de Veer","year":"2011","journal-title":"Discov. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1637\/8908-043009-Reg.1","article-title":"Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny","volume":"54","author":"De Vriese","year":"2010","journal-title":"Avian Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.20506\/rst.28.1.1865","article-title":"Experiences with vaccination in countries endemically infected with highly pathogenic avian influenza: the Food and Agriculture Organization perspective","volume":"28","author":"Domenech","year":"2009","journal-title":"Rev. Sci. Tech."},{"key":"B33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.vaccine.2016.12.011","article-title":"Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis","volume":"35","author":"Domnich","year":"2017","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vetmic.2016.04.025","article-title":"Low pathogenic avian influenza (H9N2) in chicken: evaluation of an ancestral H9-MVA vaccine","volume":"189","author":"Ducatez","year":"2016","journal-title":"Vet. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J. Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/cid\/cit272","article-title":"Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012","volume":"57","author":"Epperson","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e00286","DOI":"10.1128\/JVI.00286-17","article-title":"Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model","volume":"91","author":"Ermler","year":"2017","journal-title":"J. Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1084\/jem.124.3.331","article-title":"Disquisitions of Original Antigenic Sin. I. Evidence in man","volume":"124","author":"Fazekas de St","year":"1966","journal-title":"J. Exp. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"13418","DOI":"10.1128\/JVI.01219-14","article-title":"Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques","volume":"88","author":"Florek","year":"2014","journal-title":"J. Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1256427","article-title":"Antibody landscapes after influenza virus infection or vaccination","volume":"346","author":"Fonville","year":"2014","journal-title":"Science"},{"key":"B43","unstructured":"H7N9 Situation Update2017"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00705-017-3230-7","article-title":"Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus","volume":"162","author":"Fotouhi","year":"2017","journal-title":"Arch. Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1637\/11144-050815-ResNote","article-title":"Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges","volume":"60","author":"Gardin","year":"2016","journal-title":"Avian Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.virol.2014.10.003","article-title":"Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease","volume":"473","author":"Gauger","year":"2014","journal-title":"Virology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.vaccine.2011.01.082","article-title":"Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus","volume":"29","author":"Gauger","year":"2011","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ni1322","article-title":"Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1","volume":"7","author":"Gazit","year":"2006","journal-title":"Nat. Immunol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/IAI.44.3.730-733.1984","article-title":"Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants","volume":"44","author":"Ghendon","year":"1984","journal-title":"Infect. Immun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1017\/S1466252310000046","article-title":"Equine and canine influenza: a review of current events","volume":"11","author":"Gibbs","year":"2010","journal-title":"Anim. Health Res. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e25938","DOI":"10.1371\/journal.pone.0025938","article-title":"A human multi-epitope recombinant vaccinia virus as a universal T cell vaccine candidate against influenza virus","volume":"6","author":"Goodman","year":"2011","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1084\/jem.165.2.408","article-title":"Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes","volume":"165","author":"Gotch","year":"1987","journal-title":"J. Exp. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"E269","DOI":"10.3390\/v9100269","article-title":"Live attenuated influenza vaccine contains substantial and unexpected amounts of defective viral genomic","volume":"9","author":"Gould","year":"2017","journal-title":"R. N. A. Viruses"},{"key":"B54","volume-title":"Update on the Highly-Pathogenic Avian Influenza Outbreak of 2014\u20132015","author":"Greene","year":"2015"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2016\u201317 Influenza Season","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recommend Rep"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1016\/j.vaccine.2011.01.006","article-title":"Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate","volume":"29","author":"Grund","year":"2011","journal-title":"Vaccine"},{"key":"B57","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1637\/11166-051815-Reg","article-title":"Historical and Recent Cases of H3 Influenza A Virus in Turkeys in Minnesota","volume":"59","author":"Guo","year":"2015","journal-title":"Avian Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"10580","DOI":"10.1128\/JVI.01213-08","article-title":"Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach","volume":"82","author":"Hai","year":"2008","journal-title":"J. Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e00669","DOI":"10.1128\/mBio.00669-17","article-title":"Rationally designed influenza virus vaccines that are antigenically stable during growth in eggs","volume":"8","author":"Harding","year":"2017","journal-title":"MBio"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1099\/0022-1317-82-11-2697","article-title":"Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection","volume":"82","author":"Heinen","year":"2001","journal-title":"J. Gen. Virol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1099\/0022-1317-83-8-1851","article-title":"Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus","volume":"83","author":"Heinen","year":"2002","journal-title":"J. Gen Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.vetmic.2016.05.011","article-title":"Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs","volume":"191","author":"Hernandez","year":"2016","journal-title":"Vet. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1016\/j.vaccine.2009.05.029","article-title":"Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine","volume":"27","author":"Herzog","year":"2009","journal-title":"Vaccine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e88340","DOI":"10.1371\/journal.pone.0088340","article-title":"MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses","volume":"9","author":"Hessel","year":"2014","journal-title":"PLoS ONE"},{"key":"B65","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1099\/vir.0.048652-0","article-title":"Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses","volume":"94","author":"Hillaire","year":"2013","journal-title":"J. Gen. Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e00414","DOI":"10.1128\/CVI.00414-16","article-title":"Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults","volume":"24","author":"Hoft","year":"2017","journal-title":"Clin. Vacc. Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2165\/00063030-199911020-00007","article-title":"Liposomal influenza vaccine","volume":"11","author":"Holm","year":"1999","journal-title":"Biodrugs"},{"key":"B69","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.chom.2017.09.008","article-title":"A highly pathogenic avian H7N9 influenza virus isolated from a human is lethal in some ferrets infected via respiratory droplets","volume":"22","author":"Imai","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"254","DOI":"10.15585\/mmwr.mm6609e2","article-title":"Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017","volume":"66","author":"Iuliano","year":"2017","journal-title":"Morb Mortal Wkly. Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e01463","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio"},{"key":"B73","doi-asserted-by":"publisher","first-page":"9086","DOI":"10.1128\/JVI.00666-13","article-title":"Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: pathobiology and vaccine protection","volume":"87","author":"Kapczynski","year":"2013","journal-title":"J. Virol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.vaccine.2011.10.098","article-title":"Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs","volume":"30","author":"Kappes","year":"2012","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"11210","DOI":"10.1128\/JVI.01211-10","article-title":"Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus","volume":"84","author":"Khatri","year":"2010","journal-title":"J. Virol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-Induced Anti-HA2 Antibodies Promote Virus Fusion and Enhance Influenza Virus Respiratory Disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1637\/9369-041310-Case.1","article-title":"Isolation of highly pathogenic avian influenza H5N1 from table eggs after vaccinal break in commercial layer flock","volume":"54","author":"Kilany","year":"2010","journal-title":"Avian. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1128\/JVI.02602-07","article-title":"Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs","volume":"82","author":"Kim","year":"2008","journal-title":"J. Virol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.antiviral.2013.06.010","article-title":"Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection","volume":"99","author":"Kim","year":"2013","journal-title":"Antiviral Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.virol.2017.01.006","article-title":"A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus","volume":"503","author":"Kim","year":"2017","journal-title":"Virology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"6589","DOI":"10.1016\/j.vaccine.2009.08.032","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months","volume":"27","author":"King","year":"2009","journal-title":"Vaccine"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1128\/JVI.02372-15","article-title":"Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies","volume":"90","author":"Kirchenbaum","year":"2015","journal-title":"J. Virol."},{"key":"B83","first-page":"1691","article-title":"Orthomyxoviruses","volume-title":"Fields Virology, Vol.2, 5th Edn.","author":"Knipe","year":"2007"},{"key":"B84","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","article-title":"M2-based influenza vaccines: recent advances and clinical potential","volume":"16","author":"Kolpe","year":"2017","journal-title":"Expert Rev. Vacc."},{"key":"B85","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","article-title":"Immune responses to influenza virus infection","volume":"162","author":"Kreijtz","year":"2011","journal-title":"Virus Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"B89","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1586\/erv.12.61","article-title":"Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach","volume":"11","author":"Lambert","year":"2012","journal-title":"Expert Rev. Vacc."},{"key":"B90","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/pgmj.52.608.373","article-title":"Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine","volume":"52","author":"Laver","year":"1976","journal-title":"Postgrad. Med. J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1128\/CVI.05663-11","article-title":"Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans","volume":"19","author":"Ledgerwood","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1172\/JCI32460","article-title":"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","volume":"118","author":"Lee","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/ncomms4614","article-title":"Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus","volume":"5","author":"Lee","year":"2014","journal-title":"Nat. Commun."},{"key":"B94","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1073\/pnas.1212371109","article-title":"Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B95","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.antiviral.2015.08.001","article-title":"Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus","volume":"122","author":"Lee","year":"2015","journal-title":"Antiviral Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e12217","DOI":"10.7554\/eLife.12217","article-title":"The global antigenic diversity of swine influenza A viruses","volume":"5","author":"Lewis","year":"2016","journal-title":"Elife"},{"key":"B97","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/irv.12472","article-title":"Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken","volume":"11","author":"Li","year":"2017","journal-title":"Influenza Other Respir. Viruses."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e0120355","DOI":"10.1371\/journal.pone.0120355","article-title":"Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection","volume":"10","author":"Li","year":"2015","journal-title":"PLoS ONE"},{"key":"B99","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cid\/cis327","article-title":"Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans","volume":"55","author":"Lillie","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1128\/JVI.00031-15","article-title":"Newcastle Disease Virus-Vectored H7 and H5 live vaccines protect chickens from challenge with H7N9 or H5N1 avian influenza viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J. Virol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0165-2427(03)00019-9","article-title":"Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus","volume":"92","author":"Loeffen","year":"2003","journal-title":"Vet. Immunol. Immunopathol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1016\/j.vaccine.2017.05.010","article-title":"Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus","volume":"35","author":"Lone","year":"2017","journal-title":"Vaccine"},{"key":"B103","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1128\/JVI.01038-13","article-title":"Efficacy of inactivated and live-attenuated influenza virus vaccines in pigs against infection and transmission of emerging H3N2 similar to the 2011-2012 H3N2v","volume":"87","author":"Loving","year":"2013","journal-title":"J. Virol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1016\/j.vaccine.2012.07.033","article-title":"Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs","volume":"30","author":"Loving","year":"2012","journal-title":"Vaccine"},{"key":"B105","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1016\/j.vaccine.2014.07.011","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers","volume":"32","author":"Low","year":"2014","journal-title":"Vaccine"},{"key":"B106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jtbi.2011.08.003","article-title":"Age-specific mortality risk from pandemic influenza","volume":"288","author":"Ma","year":"2011","journal-title":"J. Theor. Biol."},{"key":"B107","first-page":"203","article-title":"Cold-adapted influenza viruses for use as live vaccines for man","volume":"14","author":"Maassab","year":"1990","journal-title":"Adv. Biotechnol. Process."},{"key":"B108","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.3390\/vaccines5030018","article-title":"Egg-Independent Influenza Vaccines and Vaccine Candidates","volume":"5","author":"Manini","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e24384","DOI":"10.1371\/journal.pone.0024384","article-title":"Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines","volume":"6","author":"Manzoli","year":"2011","journal-title":"PLoS ONE"},{"key":"B110","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.vetimm.2011.03.019","article-title":"The influence of age and maternal antibodies on the postvaccinal response against swine influenza viruses in pigs","volume":"142","author":"Markowska-Daniel","year":"2011","journal-title":"Vet. Immunol. Immunopathol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1016\/j.vaccine.2010.08.003","article-title":"Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs","volume":"28","author":"Masic","year":"2010","journal-title":"Vaccine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1586\/14760584.2013.811193","article-title":"Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults","volume":"12","author":"McElhaney","year":"2013","journal-title":"Expert Rev. Vacc."},{"key":"B113","doi-asserted-by":"publisher","first-page":"504831","DOI":"10.1155\/2015\/504831","article-title":"Current and emerging cell culture manufacturing technologies for influenza vaccines","volume":"2015","author":"Mili\u00e1n","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-7643-8371-8_7","article-title":"Correlates of protection against influenza","volume-title":"Influenza Vaccines for the Future, 2nd Edn","author":"Montomoli","year":"2008"},{"key":"B116","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.4049\/jimmunol.1502632","article-title":"Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus","volume":"196","author":"Morgan","year":"2016","journal-title":"J. Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J. Virol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1099\/vir.0.044974-0","article-title":"Global transmission of influenza viruses from humans to swine","volume":"93","author":"Nelson","year":"2012","journal-title":"J. Gen. Virol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B120","first-page":"145","article-title":"The effect of nonaqueous solvents on the quaternary structure of viruses: a procedure for the simultaneous concentration, purification and disruption of influenza viruses","volume":"4","author":"Neurath","year":"1971","journal-title":"Microbios"},{"key":"B121","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1128\/JVI.00410-16","article-title":"Rearrangement of influenza virus spliced segments for the development of live-attenuated vaccines","volume":"90","author":"Nogales","year":"2016","journal-title":"J. Virol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"12374","DOI":"10.1128\/JVI.01107-14","article-title":"The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines","volume":"88","author":"O'Donnell","year":"2014","journal-title":"J. Virol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/vaccines2040797","article-title":"A systematic review of recent advances in equine influenza vaccination","volume":"2","author":"Paillot","year":"2014","journal-title":"Vacc. (Basel)"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003019","article-title":"Emerging roles for the influenza A virus nuclear export protein (NEP)","author":"Paterson","year":"2012","journal-title":"PLoS Pathog"},{"key":"B125","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1128\/JVI.02490-12","article-title":"Influenza viruses with rearranged genomes as live-attenuated vaccines","volume":"87","author":"Pena","year":"2013","journal-title":"J. Virol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1128\/JVI.01503-10","article-title":"Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses","volume":"85","author":"Pena","year":"2011","journal-title":"J. Virol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/joim.12581","article-title":"Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up","volume":"281","author":"Persson","year":"2017","journal-title":"J. Intern. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.1128\/JVI.01131-12","article-title":"NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge","volume":"86","author":"Pica","year":"2012","journal-title":"J. Virol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clim.2016.03.008","article-title":"A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults","volume":"168","author":"Pillet","year":"2016","journal-title":"Clin. Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.virol.2016.12.001","article-title":"Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens","volume":"501","author":"Pushko","year":"2017","journal-title":"Virology"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.vaccine.2011.12.083","article-title":"Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs","volume":"30","author":"Pyo","year":"2012","journal-title":"Vaccine"},{"key":"B133","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/82_2014_391","article-title":"Pathogenesis and vaccination of influenza A virus in swine","volume-title":"Influenza Pathogenesis and Control","author":"Rajao","year":"2014"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1099\/jgv.0.000468","article-title":"Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines","volume":"97","author":"Raj\u00e3o","year":"2016","journal-title":"J. Gen. Virol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1128\/JVI.02356-10","article-title":"Effects of receptor binding specificity of avian influenza virus on the human innate immune response","volume":"85","author":"Ramos","year":"2011","journal-title":"J. Virol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-3-540-92165-3_9","article-title":"Attenuated influenza virus vaccines with modified NS1 proteins","volume":"333","author":"Richt","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.vaccine.2016.08.018","article-title":"Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: process challenges and success stories","volume":"34","author":"Rudenko","year":"2016","journal-title":"Vaccine"},{"key":"B138","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/vaccines3010022","article-title":"Optimal Use of Vaccines for Control of Influenza A Virus in Swine","volume":"3","author":"Sandbulte","year":"2015","journal-title":"Vacc. (Basel)"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e00056","DOI":"10.1128\/JVI.00056-17","article-title":"Development of an alternative modified live influenza B virus vaccine","volume":"91","author":"Santos","year":"","journal-title":"J. Virol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1016\/j.vaccine.2017.08.059","article-title":"Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys","volume":"35","author":"Santos","year":"","journal-title":"Vaccine"},{"key":"B141","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"B142","unstructured":"SchwartzJ. Midwest Canine Influenza Outbreak Caused by New Strain of Virus2015"},{"key":"B143","doi-asserted-by":"publisher","first-page":"eaam5752","DOI":"10.1126\/scitranslmed.aam5752","article-title":"A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses","volume":"9","author":"Shen","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.vaccine.2015.11.045","article-title":"Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines","volume":"34","author":"Shi","year":"2016","journal-title":"Vaccine"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e115815","DOI":"10.1371\/journal.pone.0115815","article-title":"European surveillance network for influenza in pigs: surveillance programs, diagnostic tools and Swine influenza virus subtypes identified in 14 European countries from 2010 to 2013","volume":"9","author":"Simon","year":"2014","journal-title":"PLoS ONE"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"B147","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current next generation influenza vaccines: Formulation production strategies","volume":"94","author":"Soema","year":"","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B148","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fimmu.2015.00237","article-title":"Development of cross-protective influenza a vaccines based on cellular responses","volume":"6","author":"Soema","year":"","journal-title":"Front. Immunol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.1128\/JVI.79.12.7535-7543.2005","article-title":"Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs","volume":"79","author":"Sol\u00f3rzano","year":"2005","journal-title":"J. Virol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1128\/JVI.00893-07","article-title":"A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates","volume":"81","author":"Song","year":"2007","journal-title":"J. Virol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.tvjl.2014.09.017","article-title":"Practical aspects of vaccination of poultry against avian influenza virus","volume":"202","author":"Spackman","year":"2014","journal-title":"Vet. J."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.virusres.2017.01.025","article-title":"A prime\/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1","volume":"232","author":"Stachyra","year":"2017","journal-title":"Virus Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"e00018","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"B155","doi-asserted-by":"publisher","first-page":"839","DOI":"10.20506\/rst.30.3.2081","article-title":"Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination","volume":"30","author":"Swayne","year":"2011","journal-title":"Rev. Sci. Tech."},{"key":"B156","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/9781119421481","article-title":"Influenza","volume-title":"Diseases of Poultry, 13th Edn.","author":"Swayne","year":"2013"},{"key":"B157","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1016\/j.vaccine.2007.02.011","article-title":"Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection","volume":"25","author":"Sylte","year":"2007","journal-title":"Vaccine"},{"key":"B158","doi-asserted-by":"publisher","first-page":"e02462","DOI":"10.1128\/JVI.02462-16","article-title":"Recombinant Adenoviruses Displaying Matrix 2 Ectodomain Epitopes on Their Fiber Proteins as Universal Influenza Vaccines","volume":"91","author":"Tang","year":"2017","journal-title":"J. Virol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.antiviral.2017.01.021","article-title":"Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses","volume":"141","author":"Tao","year":"2017","journal-title":"Antiviral Res."},{"key":"B160","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.4049\/jimmunol.0902497","article-title":"Neutrophils ameliorate lung injury and the development of severe disease during influenza infection","volume":"183","author":"Tate","year":"2009","journal-title":"J. Immunol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","volume":"3","author":"Taubenberger","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"187","DOI":"10.20506\/rst.28.1.1879","article-title":"Pandemic influenza\u2013including a risk assessment of H5N1","volume":"28","author":"Taubenberger","year":"2009","journal-title":"Rev. Sci. Tech."},{"key":"B163","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1086\/507558","article-title":"Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease","volume":"194","author":"Thompson","year":"2006","journal-title":"J. Infect. Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"B165","volume-title":"Veterinary Biological Products: Licensees and Permittees","year":"2014"},{"key":"B166","doi-asserted-by":"publisher","first-page":"e0150146","DOI":"10.1371\/journal.pone.0150146","article-title":"Antibody persistence in adults two years after vaccination with an H1N1 2009 pandemic influenza virus-like particle vaccine","volume":"11","author":"Valero-Pacheco","year":"2016","journal-title":"PLoS ONE"},{"key":"B167","doi-asserted-by":"publisher","first-page":"22666","DOI":"10.1038\/srep22666","article-title":"Stalking influenza by vaccination with pre-fusion headless HA mini-stem","volume":"6","author":"Valkenburg","year":"2016","journal-title":"Sci. Rep."},{"key":"B168","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/infdis\/jiv018","article-title":"Human Influenza A Virus-Specific CD8+ T-Cell Response Is Long-lived","volume":"212","author":"van de Sandt","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1016\/j.vaccine.2009.03.021","article-title":"Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus","volume":"27","author":"Van Reeth","year":"2009","journal-title":"Vaccine"},{"key":"B170","first-page":"557","article-title":"Influenza virus","volume-title":"Diseases of Swine, 10th Edn","author":"Van Reeth","year":"2012"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.vaccine.2012.01.030","article-title":"Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine","volume":"30","author":"Vander Veen","year":"2012","journal-title":"Vaccine"},{"key":"B172","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/vr.101741","article-title":"Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus","volume":"173","author":"Vander Veen","year":"2013","journal-title":"Vet. Rec"},{"key":"B173","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1016\/j.vaccine.2009.02.004","article-title":"MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination","volume":"27","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children","volume":"365","author":"Vesikari","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B175","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.vetmic.2007.07.011","article-title":"Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine","volume":"126","author":"Vincent","year":"2008","journal-title":"Vet. Microbiol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41598-017-02019-1","article-title":"Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"B177","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/333426a0","article-title":"Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid","volume":"333","author":"Weis","year":"1988","journal-title":"Nature"},{"key":"B178","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/j.vaccine.2004.02.040","article-title":"Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus","volume":"22","author":"Wesley","year":"2004","journal-title":"Vaccine"},{"key":"B179","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B180","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"e1002998","DOI":"10.1371\/journal.ppat.1002998","article-title":"Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain","volume":"8","author":"Wise","year":"2012","journal-title":"PLoS Pathog"},{"key":"B182","doi-asserted-by":"publisher","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"key":"B183","unstructured":"Influenza (Seasonal).2016"},{"key":"B184","unstructured":"Cumulative Number of Confirmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003-2017.2017"},{"key":"B185","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/irv.12230","article-title":"Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses","volume":"8","year":"2014","journal-title":"Influenza Other Respi Virus."},{"key":"B186","doi-asserted-by":"publisher","first-page":"8868","DOI":"10.1016\/j.vaccine.2007.09.056","article-title":"Characterization of immunity induced by M2e of influenza virus","volume":"25","author":"Wu","year":"2007","journal-title":"Vaccine"},{"key":"B187","doi-asserted-by":"publisher","first-page":"7451","DOI":"10.1016\/j.vaccine.2009.05.014","article-title":"Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1)","volume":"27","author":"Yang","year":"2009","journal-title":"Vaccine"},{"key":"B188","doi-asserted-by":"publisher","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS Pathog."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014-2015 influenza vaccine effectiveness in the united states by vaccine type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin. Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:35:49Z","timestamp":1603798549000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":189,"alternative-id":["10.3389\/fmicb.2018.00123"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00123","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"article-number":"123"}}